expert roundtables by Leonard H. Calabrese, DO, Jeffrey R. Curtis, MD, MS, MPH, Eric M. Ruderman, MD
Pathobiology-guided therapy has long been a goal in the treatment of patients with rheumatoid arthritis (RA). Despite limited success in the past, ......READ MORE
patient care perspectives by Jeffrey R. Curtis, MD, MS, MPH
There is a clear link between obesity in rheumatoid arthritis (RA) and greater disease activity and less robust responses to disease-modifying ther......READ MORE
patient care perspectives by Leonard H. Calabrese, DO
There is often a gap between how a physician assesses treatment success and the end points that are most important to the patient. Physicians tend ......READ MORE
patient care perspectives by Alvin F. Wells, MD, PhD
Obesity can adversely affect response to disease-modifying antirheumatic therapies, with anti–tumor necrosis factor (anti-TNF) agents among the mos......READ MORE
expert roundtables by Leonard H. Calabrese, DO, Stanley B. Cohen, MD, Alan L. Epstein, MD, Daniel E. Furst, MD
Although personalized therapy in rheumatoid arthritis (RA) is not yet a reality, panelists hope that data gathered over the last decade, together w......READ MORE
expert roundtables by Leonard H. Calabrese, DO, Stanley B. Cohen, MD, Alan L. Epstein, MD, Daniel E. Furst, MD
Experts describe a significant psychiatric overlay in a subgroup of patients with rheumatoid arthritis (RA). Perhaps as many as one-fourth of patie......READ MORE
